{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:17:04Z","timestamp":1788218224542,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.7759\/cureus.115541","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:58:59Z","timestamp":1788217139000},"source":"Crossref","is-referenced-by-count":0,"title":["Gut Colonization With Carbapenem-Resistant Enterobacteriaceae in COVID-19-Recovered Patients: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Priyam","family":"Batra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajisha","family":"Aravindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyankar K","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Roy Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwari","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101848","article-title":"Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022","volume":"57","author":"Nandi A","year":"2023","unstructured":"Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022. EClinicalMedicine. 2023, 57:101848. 10.1016\/j.eclinm.2023.101848","journal-title":"EClinicalMedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford BJ","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, et al.. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021, 27:520-31. 10.1016\/j.cmi.2020.12.018","journal-title":"Clin Microbiol Infect"},{"key":"ref3","unstructured":"COVID-19. U.S. impact on antimicrobial resistance, special report 2022. (2022). https:\/\/stacks.cdc.gov\/view\/cdc\/119025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.12.006","article-title":"Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis","volume":"29","author":"Langford BJ","year":"2023","unstructured":"Langford BJ, Soucy JR, Leung V, et al.. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infect. 2023, 29:302-9. 10.1016\/j.cmi.2022.12.006","journal-title":"Clin Microbiol Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.12.022","article-title":"Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review","volume":"16","author":"Abubakar U","year":"2023","unstructured":"Abubakar U, Al-Anazi M, Alanazi Z, Rodr\u00edguez-Ba\u00f1o J. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. J Infect Public Health. 2023, 16:320-31. 10.1016\/j.jiph.2022.12.022","journal-title":"J Infect Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/life11111127","article-title":"Clostridioides difficile and vancomycin-resistant enterococci in COVID-19 patients with severe pneumonia","volume":"11","author":"Bogdanov\u00e1 K","year":"2021","unstructured":"Bogdanov\u00e1 K, Doubravsk\u00e1 L, V\u00e1gnerov\u00e1 I, et al.. Clostridioides difficile and vancomycin-resistant enterococci in COVID-19 patients with severe pneumonia. Life (Basel). 2021, 11:1127. 10.3390\/life11111127","journal-title":"Life (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231165581","article-title":"The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation","volume":"16","author":"Bachour SP","year":"2023","unstructured":"Bachour SP, Dalal R, Allegretti JR. The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation. Ther Adv Gastroenterol. 2023, 16:17562848231165581. 10.1177\/17562848231165581","journal-title":"Ther Adv Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2021.113882","article-title":"Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure","volume":"240","author":"Kang Y","year":"2022","unstructured":"Kang Y, Chen S, Chen Y, Tian L, Wu Q, Zheng M, Li Z. Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure. Int J Hyg Environ Health. 2022, 240:113882. 10.1016\/j.ijheh.2021.113882","journal-title":"Int J Hyg Environ Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38251","article-title":"Antibiotic resistance and its impact on disease management","volume":"15","author":"Nadgir CA","year":"2023","unstructured":"Nadgir CA, Biswas DA. Antibiotic resistance and its impact on disease management. Cureus. 2023, 15:e38251. 10.7759\/cureus.38251","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00341-16","article-title":"Multisite evaluation of Cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs","volume":"54","author":"Tato M","year":"2016","unstructured":"Tato M, Ruiz-Garbajosa P, Traczewski M, et al.. Multisite evaluation of Cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs. J Clin Microbiol. 2016, 54:1814-9. 10.1128\/JCM.00341-16","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.9734\/JAMB\/2018\/43928","article-title":"Endemicity of OXA-48 and NDM-1 carbapenemase producing Klebsiella pneumoniae and Escherichia coli from a tertiary hospital in Varanasi, India","volume":"12","author":"Filgona J","year":"2018","unstructured":"Filgona J, Banerjee T, Anupurba S. Endemicity of OXA-48 and NDM-1 carbapenemase producing Klebsiella pneumoniae and Escherichia coli from a tertiary hospital in Varanasi, India. J Adv Microbiol. 2018, 12:1-8. 10.9734\/JAMB\/2018\/43928","journal-title":"J Adv Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01497-10","article-title":"Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007","volume":"55","author":"Castanheira M","year":"2011","unstructured":"Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2011, 55:1274-8. 10.1128\/AAC.01497-10","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94303","article-title":"The rising menace: carbapenem-resistant klebsiella pneumoniae in a tertiary care center and co-dominance of blaNDM, blaOXA-48 along with the emergence of blaVIM","volume":"17","author":"Muneer F","year":"2025","unstructured":"Muneer F, Raj N, Das A, Singh V, Sen M, Agarwal J. The rising menace: carbapenem-resistant klebsiella pneumoniae in a tertiary care center and co-dominance of blaNDM, blaOXA-48 along with the emergence of blaVIM. Cureus. 2025, 17:e94303. 10.7759\/cureus.94303","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/528447-gut-colonization-with-carbapenem-resistant-enterobacteriaceae-in-covid-19-recovered-patients-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:59:00Z","timestamp":1788217140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/528447-gut-colonization-with-carbapenem-resistant-enterobacteriaceae-in-covid-19-recovered-patients-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.115541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}